<p>The invention provides an immunogenic composition comprising: a) a conjugate that is a capsular saccharide from GBS serotype la conjugated to a carrier protein; b) a conjugate that is a capsular saccharide from GBS serotype lb conjugated to a carrier protein; and c) a conjugate that is a capsular saccharide from GBS serotype III conjugated to a carrier protein. The invention also provides a method for immunising a patient against infection by GBS comprising the step of administering to the patient a conjugate that is a capsular saccharide from GBS conjugated to a diphtheria toxoid or derivative thereof, wherein the patient has been pre-immunised with a diphtheria toxoid or derivative thereof.</p>
申请公布号
AU2011303478(A1)
申请公布日期
2013.04.04
申请号
AU20110303478
申请日期
2011.09.16
申请人
NOVARTIS AG
发明人
BERTI, FRANCESCO;CONTORNI, MARIO;COSTANTINO, PAOLO;FINCO, ORETTA;GRANDI, GUIDO;MAIONE, DOMENICO;TELFORD, JOHN